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RESEARCH
Accelerated high-resolution free-breathing 
3D whole-heart  T2-prepared black-blood 
and bright-blood cardiovascular magnetic 
resonance
Teresa Correia1* , Giulia Ginami1, Imran Rashid1, Giovanna Nordio1, Reza Hajhosseiny1, Tevfik F. Ismail1, 
Radhouene Neji1,2, René M. Botnar1,3 and Claudia Prieto1,3
Abstract 
Background: The free-breathing 3D whole-heart  T2-prepared Bright-blood and black-blOOd phase SensiTive inver-
sion recovery (BOOST) cardiovascular magnetic resonance (CMR) sequence was recently proposed for simultane-
ous bright-blood coronary CMR angiography and black-blood late gadolinium enhancement (LGE) imaging. This 
sequence enables simultaneous visualization of cardiac anatomy, coronary arteries and fibrosis. However, high-resolu-
tion (< 1.4 × 1.4 × 1.4  mm3) fully-sampled BOOST requires long acquisition times of ~ 20 min.
Methods: In this work, we propose to extend a highly efficient respiratory-resolved motion-corrected reconstruction 
framework (XD-ORCCA) to  T2-prepared BOOST to enable high-resolution 3D whole-heart coronary CMR angiography 
and black-blood LGE in a clinically feasible scan time. Twelve healthy subjects were imaged without contrast injec-
tion (pre-contrast BOOST) and 10 patients with suspected cardiovascular disease were imaged after contrast injec-
tion (post-contrast BOOST). A quantitative analysis software was used to compare accelerated pre-contrast BOOST 
against the fully-sampled counterpart (vessel sharpness and length of the left and right coronary arteries). Moreover, 
three cardiologists performed diagnostic image quality scoring for clinical 2D LGE and both bright- and black-blood 
3D BOOST imaging using a 4-point scale (1–4, non-diagnostic–fully diagnostic). A two one-sided test of equivalence 
(TOST) was performed to compare the pre-contrast BOOST images. Nonparametric TOST was performed to compare 
post-contrast BOOST image quality scores.
Results: The proposed method produces images from 3.8 × accelerated non-contrast-enhanced BOOST acquisitions 
with comparable vessel length and sharpness to those obtained from fully- sampled scans in healthy subjects. Moreo-
ver, in terms of visual grading, the 3D BOOST LGE datasets (median 4) and the clinical 2D counterpart (median 3.5) were 
found to be statistically equivalent (p < 0.05). In addition, bright-blood BOOST images allowed for visualization of the 
proximal and middle left anterior descending and right coronary sections with high diagnostic quality (mean score > 3.5).
Conclusions: The proposed framework provides high‐resolution 3D whole-heart BOOST images from a single free-
breathing acquisition in ~ 7 min.
Keywords: Late gadolinium enhancement (LGE), Coronary magnetic resonance angiography (CMRA), Black-blood, 
Compressed sensing, Image navigator, Respiratory motion compensation
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Background
Late gadolinium enhancement (LGE) cardiovascular 
magnetic resonance (CMR) imaging has emerged as the 
clinical reference standard for assessing viability follow-
ing myocardial infarction [1, 2]. Moreover, LGE imaging 
is gaining importance in the diagnostic and prognos-
tic evaluation of a range of heart muscle diseases where 
fibrosis can develop [3–7]. LGE imaging is performed 
after the administration of a gadolinium (Gd)-based 
contrast agent using inversion recovery (IR) prepared 
 T1-weighted gradient echo sequences [1, 8–10]. The 
inversion time (TI) is set to null the signal of healthy 
myocardium in order to maximize the contrast between 
infarcted/fibrotic and normal myocardium. This method 
is highly dependent on the correct selection of TI for 
healthy myocardial signal nulling.
Phase-sensitive IR (PSIR) LGE is an alternative 
approach that is less sensitive to the TI selection [11, 12]. 
Conventional PSIR sequences require an IR-prepared 
image (or “magnitude image”) and a proton density 
weighted image (or “reference image”) to provide a refer-
ence for background phase. However, conventional PSIR 
sequences provide suboptimal contrast between scar tis-
sue and the blood pool, meaning that sub-endocardial 
infarctions could be difficult to detect or delineate.
Black-blood PSIR LGE schemes have been proposed 
to improve scar-blood contrast by suppressing both the 
healthy myocardium and blood pool signal [13]. This 
can be achieved by combining an inversion pulse with 
a  T2 preparation or magnetization transfer prepara-
tion [13–16]. Most existing PSIR LGE sequences are, 
however, limited to 2D acquisitions that are performed 
under a breath-hold. Recently, free-breathing 3D whole-
heart PSIR acquisitions based on diaphragmatic naviga-
tor gating have been proposed [17, 18]. However, these 
approaches have low scan efficiency that lead to long and 
unpredictable acquisition times, and thus, may result in 
reduced image quality due to the change of the TI over 
time as well as disrupted workflows. In addition, PSIR 
sequences require the acquisition of a reference image, 
which doubles the scan time without providing additional 
diagnostic information. Recently, Ginami et al. proposed 
a free-breathing 3D whole-heart  T2-prepared Bright-
blood and black-blOOd phase SensiTive inversion recov-
ery sequence (BOOST) for simultaneous bright-blood 
coronary angiography and black-blood LGE imaging [19]. 
With BOOST, magnitude and (bright-blood) reference 
whole heart datasets are acquired and combined in a PSIR 
reconstruction to obtain a third, complementary, black-
blood volume. Additionally, BOOST uses image-based 
navigators (iNAVs) [20] to achieve 100% respiratory scan 
efficiency and predictable scan times. The  T2-prepared 
BOOST sequence allows for visualization of myocardial 
infarction with excellent scar-blood contrast. In addition, 
the reference image provides a complementary bright-
blood volume for cardiac anatomy and coronary lumen 
visualization (coronary CMR angiography, CCMRA). 
However, high spatial resolution  T2-prepared BOOST 
(< 1.4 × 1.4 × 1.4  mm3) requires relatively long acquisition 
times of ~ 20 min. Yet, high-resolution 3D BOOST acqui-
sitions are required to ensure accurate detection of scar 
location, size and transmurality, and identify coronary 
stenosis. This information is important to risk-stratify 
patients and guide revascularization decisions.
A non-contrast-enhanced version of BOOST has also 
shown potential for simultaneous bright- and black-
blood whole-heart CMR for coronary lumen and throm-
bus visualization [21]. However, like post-contrast 
BOOST, high-resolution non-contrast-enhanced BOOST 
also requires long acquisition times.
Here, we propose to accelerate the  T2-prepared 
BOOST sequence to enable high-resolution whole-heart 
3D CCMRA and black-blood PSIR imaging in a clini-
cally feasible scan time (< 10  min). This is achieved by 
extending XD-ORCCA (Optimized Respiratory resolved 
Cartesian CCMRA) [22], a highly efficient respiratory-
resolved motion-corrected reconstruction framework, 
to BOOST imaging. XD-ORCCA reconstruction, which 
was originally introduced for fully-sampled 3D Cartesian 
CCMRA, exploits 2D translational motion information 
(extracted from iNAVs) to increase the sparsity in the 
respiratory dimension and to compensate for residual 
respiratory motion [22]. In this study, the feasibility of 
accelerating the  T2-prepared 3D BOOST sequence [19, 
21] using XD-ORCCA was tested in 10 patients with sus-
pected cardiovascular disease, using an accelerated post-
contrast BOOST sequence, at the end of a clinical CMR 
examination. Due to technical and ethical limitations, it 
is difficult to test new contrast-enhanced CMR sequences 
in patients and thus, the optimal acceleration factor 
employed was identified by first testing different accel-
eration factors using non-contrast-enhanced 3D BOOST 
acquisitions in 12 healthy subjects.
Methods
T2‑prepared BOOST sequence
The  T2-prepared BOOST sequence alternates the acqui-
sition of a  T2-prepared IR module in odd heartbeats 
 (T2Prep-IR, magnitude image) and a  T2-prepared module 
in even heartbeats  (T2Prep, reference image), as shown in 
Fig. 1a and b. Both undersampled datasets are acquired 
using a 3D variable-density Cartesian trajectory with 
spiral profile order (VD-CASPR) [23–25]. A short tau 
inversion recovery (STIR)-like fat suppression approach 
[26] is used in odd heartbeats, whereas a spectral pre-
saturation (SPIR) [27] is used to suppress epicardial fat 
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signal in even heartbeats. Low-resolution 2D iNAVs are 
acquired at every heartbeat to estimate 2D beat-to-beat 
translational motion (left–right: LR and superior-infe-
rior: SI) and enable 100% respiratory scan efficiency and 
a predictable scan time. Motion estimation is performed 
independently for both BOOST datasets.
In post-contrast BOOST a subject-specific TI is set 
to null the signal from the healthy viable myocardium, 
whereas in non-contrast-enhanced BOOST a short 
TI = 110 ms is set to null the fat signal.
XD‑ORCCA reconstruction
The iNAVs are registered to a common respiratory posi-
tion (end-expiration) and the 2D translational motion 
parameters are obtained via intensity-based image regis-
tration, using mutual information as a similarity measure 
and steepest gradient descent optimization. Then, the 
estimated SI information is used to obtain the respira-
tory signal, which is used to distribute each BOOST 
dataset into five equally populated respiratory bins 
(Fig.  2a). Subsequently, 2D translational motion cor-
rection within each bin is performed in k-space before 
respiratory-resolved image reconstruction to minimize 
intra-bin motion (Fig.  2b). This motion information is 
also used during the reconstruction to align the intra-bin 
motion-corrected images to end-expiration (Fig.  2c), in 
order to increase the sparsity in the respiratory domain 
[22]. Therefore, respiratory-resolved  T2Prep-IR BOOST 
and bright-blood  T2Prep BOOST images (Fig.  2d) are 
obtained by solving a modified version of XD-ORCCA, 
which explores the temporal sparsity in both forward and 
Fig. 1 Proposed 3D whole-heart high-resolution motion-resolved accelerated  T2-prepared Bright-blood and black-blOOd phase SensiTive inversion 
recovery (BOOST) for simultaneous black-blood late gadolinium enhancement (LGE) and bright-blood coronary cardiovascular magnetic resonance 
angiography (CCMRA). a A  T2-prepared  (T2Prep) inversion recovery (IR) module is applied at odd heartbeats  (T2Prep-IR BOOST, magnitude image), 
whereas a b  T2-prepared module is acquired at even heartbeats  (T2Prep BOOST, reference image). In the latter, a SPIR pulse is used for fat saturation. 
In the former, the inversion time (TI) is set to null the signal from healthy viable myocardium and the fat signal is suppressed using a STIR-like 
fat approach. Both acquisitions are performed using a variable-density 3D Cartesian trajectory with spiral profile order and a high flip-angle 
of 90°. A low-resolution 2D image navigator (iNAV) is acquired at every heartbeat, before each spiral interleave of the 3D data acquisition, to 
estimate translational respiratory motion along the superior-inferior and left–right directions. c This motion information is used in the XD-ORCCA 
reconstruction to generate high-quality respiratory-resolved motion-compensated  T2Prep-IR BOOST and  T2Prep BOOST images from undersampled 
acquisitions. Then, the respiratory bin images are combined in a PSIR reconstruction to d generate a black-blood LGE image (PSIR BOOST) for scar 
visualization. The bright-blood  T2Prep BOOST image (reference image, b) allows for coronary lumen visualization
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backward directions, instead of a unique direction, to 
further increase the sparsity [22]:
where d are the 2D intra-bin translational motion-cor-
rected k-space data, s is the 3D spatial total variation 
(TV) function, α, β and γ are regularization param-
eters, Rx = Tbxb is the motion-corrected domain, 
where Tb is the translation transform that maps the 
respiratory bin image xb to the reference image x1 
(end-expiration), t = �Tbxb − Tb+1xb+1�1 and 





� Ex − d �22 + α�t(Rx)+ β�−t(Rx)+ γ�s(x)
}
,
−t = �Tbxb − Tb−1xb−1�1 are 1D temporal TV func-
tions in the forward and backward directions, respec-
tively. The operator E = AbFS incorporates the sampling 
matrix A for each bin b, Fourier transform F and coil sen-
sitivities S . The regularization parameters were selected 
empirically. Finally, the  T2Prep-IR BOOST and bright-
blood  T2Prep BOOST images from the bin with the 
smallest respiratory SI displacement (usually end-expira-
tion, Fig.  1c) are combined in a PSIR reconstruction to 
generate a 3D black-blood PSIR BOOST image (Fig. 1d).
In‑vivo experiments
All acquisitions reported in this study were performed 
on a 1.5T CMR system (MAGNETOM Aera, Siemens 
Healthineers, Erlangen, Germany) using an 18-chan-
nel chest-coil and a 32-channel spine coil. The study 
was approved by the National Research Ethics Service 
(1/11/12 and 15/NS/0030) and written informed consent 
was obtained from each participant according to institu-
tional guidelines.
The 2D iNAVs were acquired using 14 ramp-up prep-
aration pulses of the 3D whole-heart balanced steady 
state free precession (bSSFP) sequence with the same 
field-of-view (FOV) and orientation as the 3D BOOST 
acquisition.
Non‑contrast‑enhanced BOOST acquisitions: selection 
of undersampling factor
In-vivo free-breathing non-contrast-enhanced 3D 
BOOST acquisitions were performed in 12 healthy 
subjects (32 ± 8  years, 5 males, heart rate 57 beats/
minute). Fully-sampled BOOST (with elliptical 
k-space coverage), 2.6 × and 3.8 × accelerated acqui-
sitions were performed in a randomized order for 
each subject using the following parameters: coronal 
orientation, FOV = 320 × 320 × 96–112  mm3, resolu-
tion = 1 × 1 × 2  mm3, (repetition time) TR/ (echo time) 
TE = 3.6/1.56  ms, pixel bandwidth = 977  Hz/pixel, flip 
angle = 90°, TI = 110  ms,  T2Prep = 40  ms, subject-spe-
cific mid-diastolic trigger delay and acquisition window 
(corresponding to 28–40  k-space readouts per heart-
beat). Acquisition time for the fully-sampled, 2.6 × and 
3.8 × accelerated non-contrast-enhanced BOOST 
approach was 17:12 ± 2:5  min, 8:38 ± 1:3  min, and 
5:36 ± 0:46 min, respectively.
The bright-blood  T2Prep BOOST images (interpolated 
to 0.6 × 0.6 × 0.6  mm3) were reformatted using SoapBub-
ble [28] to allow simultaneous visualization of the right 
Fig. 2 XD-ORCCA reconstruction: Low-resolution 2D iNAVs are 
acquired at every heartbeat and used to estimate beat-to-beat 2D 
translational respiratory motion along the superior-inferior (SI) and 
left–right (LR) directions. a The estimated SI motion information is 
used to separate the  T2Prep-IR BOOST and  T2Prep BOOST datasets 
into five different respiratory phases (or bins) each. b Moreover, 
2D translational motion correction within each bin is performed 
in k-space before reconstruction to minimize intra-bin motion. In 
this step, data within each bin are corrected to the corresponding 
average bin position. c Finally, during image reconstruction, intra-bin 
motion-corrected images  (xb) are aligned to a reference respiratory 
position (end-expiration) using the 2D translational motion 
information  (Tb), in order to increase the sparsity in the respiratory 
dimension and d generate high-quality motion-compensated 
respiratory-resolved images
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coronary artery (RCA), left anterior descending coronary 
artery (LAD) and whenever possible the left circumflex 
coronary artery (LCX). Using the same software, coro-
nary percentage vessel sharpness (first 4  cm and full 
length) and visible vessel length of both RCA and LAD 
were measured for all acquisitions. A Two One-Sided 
Test of Equivalence (TOST), as described in [29], was 
used to compare the quantitative results obtained from 
undersampled acquisitions to those obtained from the 
fully-sampled reference. If p-value < 0.05, the test rejects 
the null hypothesis of non-equivalence and accepts the 
alternative hypothesis of equivalence.
Contrast‑enhanced BOOST acquisitions
Free-breathing contrast-enhanced 3D whole-heart 
BOOST and conventional breath-hold 2D PSIR LGE 
acquisitions were performed in 10 patients (66 ± 15 year, 
7 males, average heart rate 58 beats/minute) with sus-
pected cardiovascular disease. First, the multi-slice and 
multi-breath-hold 2D PSIR LGE clinical sequence (four 
chamber view; three chamber view; short-axis view) was 
acquired ~ 10  min after Gadobutrol (Gadovist, Bayer 
Healthcare, Berlin, Germany) injection (0.2  mmol/
kg) with bSSFP readout, in-plane spatial resolu-
tion = 1.4 × 1.4  mm2, slice thickness = 8 mm, 10–12 slices 
for the short axis view, FOV = 340 × 360  mm2, TR/
TE = 2.9/1.2  ms, pixel bandwidth = 780  Hz/pixel, flip 
angle = 45°, and subject-specific mid-diastolic trigger 
delay. The TI (ranging in the interval 225–310  ms) was 
selected with a dedicated TI scout scan and was set to 
null the signal from the healthy myocardium.
At the end of the clinical protocol, post-contrast 
BOOST acquisitions were performed (~ 25–40  min 
after injection) using the following parameters: coronal 
orientation, FOV = 320 × 320 × 96–128  mm3, resolu-
tion = 1 × 1 × 2  mm3, TR/TE = 3.6/1.57  ms, pixel band-
width 977  Hz/pixel, flip-angle = 90°,  T2Prep = 40  ms, 
3.8-fold undersampling, subject-specific mid-diastolic 
trigger delay (corresponding to 20–40  k-space readouts 
per heartbeat) and acquisition time 7:14 ± 2:57 min. The 
subject-specific TI (90–150 ms) was selected to null the 
signal from viable healthy myocardium and was identi-
fied using a dedicated 2D BOOST TI scout scan during 
breath-hold. The 2D BOOST TI scout scan consisted of a 
magnetization-prepared cine sequence with a T2Prep-IR 
module applied right after the R-wave at odd heartbeats 
and T2-preparation only at even heartbeats [30].
Blinded qualitative grading of anonymized clinical 2D 
PSIR and 3D PSIR BOOST images was performed on 
consensus basis by three cardiologists (T.F.I, I.R., SCMR 
III accredited, and R.H., SCMR II accredited). Images 
were stored as grayscale digital imaging and communica-
tions in medicine (DICOM) images and were windowed 
so that the black-blood PSIR BOOST showed a black 
blood pool, which was darker than the healthy myocar-
dium, whereas in the clinical 2D PSIR the normal myo-
cardium was black (with noise still visible). LGE uptake 
was bright in both 3D PSIR BOOST and 2D PSIR. The 
diagnostic quality of the clinical 2D PSIR and 3D PSIR 
BOOST images was graded using a 4-point scale: (1) 
non-diagnostic, (2) diagnostic with major artifacts, (3) 
diagnostic with minor artifacts and (4) fully diagnostic 
with no artifacts. LGE visualization scores were com-
pared using a nonparametric TOST based on the Wil-
coxon signed-rank test [31]. The level of significance of 
the p-value was 0.05. The diagnostic quality of the proxi-
mal, mid and distal sections of the LAD, LCX, and RCA 
course, was graded using the same 4-point scale. BOOST 
images whose acquisition started later than 40 min after 
contrast injection were not considered in the analysis, 
because the relative contrast between normal and dis-
eased myocardium significantly decreases due to contrast 
agent washout.
Results
Non‑contrast‑enhanced BOOST acquisitions: selection 
of undersampling factor
Free-breathing BOOST acquisitions and motion-resolved 
reconstructions with intra-bin motion compensation 
were successfully obtained for all 12 subjects. The refor-
matted bright-blood  T2Prep BOOST and black-blood 
PSIR BOOST images (respiratory phase with the smallest 
SI respiratory displacement) obtained using the proposed 
method from fully-sampled, 2.6 × and 3.8 × undersam-
pled acquisitions for a representative healthy subject are 
shown in Fig. 3. In addition, the reformatted bright-blood 
 T2Prep BOOST images obtained from fully-sampled 
and undersampled data for another two representative 
healthy subjects are shown in Fig. 4. For subject 3 (Fig. 3, 
right), the tortuous anatomy of the RCA prevented an 
appropriate reformatting of the mid segment of the ves-
sel. However, the mid-RCA was successfully recon-
structed from accelerated BOOST acquisitions using the 
proposed method (Additional file 1).
The RCA and LAD visible vessel lengths measured 
from the images reconstructed from fully-sampled, 
2.6 × and 3.8 × undersampled datasets are shown in 
Fig.  5a. The average visible vessel lengths for the RCA 
were 10.1 ± 1.6  cm, 10.4 ± 1.7  cm and 10.3 ± 1.7  cm for 
the fully-sampled, 2.6 × and 3.8 × undersampled data-
sets, respectively. For the LAD, the corresponding aver-
age vessel lengths were 10.3 ± 3.8 cm, 10.0 ± 3.5 cm and 
9.9 ± 3.5 cm. Statistically significant equivalence (p < 0.05) 
was found in visible vessel length when comparing meas-
urements from fully-sampled and undersampled BOOST 
Page 6 of 12Correia et al. J Cardiovasc Magn Reson           (2020) 22:88 
images, for both coronary arteries. Additionally, statisti-
cally significant equivalence was found in the sharpness 
of both coronary arteries between the images obtained 
from fully-sampled and undersampled BOOST acquisi-
tions (Fig. 5b). The vessel sharpness for the first 4 cm of 
the RCA was (fully-sampled) 64 ± 5%, (2.6 ×) 62 ± 6% 
and (3.8x) 59 ± 11%. For the LAD the vessel sharpness 
was (fully-sampled) 63 ± 5%, (2.6x) 61 ± 6% and (3.8 ×) 
61 ± 5%.
The proposed method produces images from 2.6 × and 
3.8 × accelerated BOOST acquisitions with compara-
ble visual quality to those obtained from fully-sampled 
BOOST acquisitions (Additional file 2).
Contrast‑enhanced BOOST acquisitions
Clinical and demographic characteristics are summarized 
in Table 1. Patient 6 and patient 9 were not included in 
the qualitative analysis because BOOST data acquisition 
started more than 40 min after contrast agent injection. 
In addition, for patient 6, residual motion artifacts were 
visible in the BOOST images, which resulted from the 
rigid translation of the chest walls and arms. Moreover, 
patient 9 exhibited very irregular heartbeats, very short 
diastolic window and was not able to breath-hold, mak-
ing the acquisition of CMR exam images very challeng-
ing, including the clinical 2D PSIR images, which further 
delayed the BOOST acquisition. Therefore, image qual-
ity analysis was performed for 8 of 10 patients. The aver-
age time after injection for BOOST acquisitions was 
32 ± 7 min.
All eight 3D PSIR BOOST datasets were considered 
diagnostic, with a median grade of 4 (range 3–4); specifi-
cally, 5/8 cases were graded 4 and 3 cases were graded 3. 
Clinical 2D PSIR images were graded 4 for 4 patients, 3 
cases were graded 3 and one case was graded 2 (median 
score 3.5, range 2–4). In terms of visual grading, the 3D 
PSIR BOOST datasets and the clinical 2D PSIR counter-
part were found to be statistically equivalent (p < 0.05).
The clinical 2D PSIR and 3D BOOST images  (T2Prep, 
PSIR and fusion of  T2Prep and PSIR images) are shown 
in Fig.  6 for a patient with myocardial infarction. LGE 
uptake can be seen in the mid and basal anterolateral 
walls in both 3D PSIR BOOST and 2D clinical images. 
Some LGE uptake can also be seen in the septal wall in 
Fig. 3 Reformatted  T2Prep-IR BOOST and PSIR BOOST images 
obtained for one representative healthy subject using the proposed 
framework. Images were reconstructed from fully-sampled, 2.6 × and 
3.8 × undersampled BOOST datasets and display the right (RCA), left 
anterior descending (LAD) and left circumflex artery (LCX) coronary 
arteries. Images obtained from accelerated BOOST acquisitions have 
similar quality to those obtained from the fully-sampled BOOST 
acquisition, allowing for clear visualization of the coronary arteries. 
Total acquisition times are indicated for each acquisition
Fig. 4 Reformatted  T2Prep-IR BOOST images obtained for two 
representative healthy subjects, displaying the right (RCA), left 
anterior descending (LAD) and left circumflex (LCX) coronary 
arteries. Images were reconstructed from fully-sampled, 2.6 × and 3.8 
undersampled BOOST datasets. Images obtained from accelerated 
acquisitions have comparable quality to those obtained from 
fully-sampled BOOST acquisitions
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the 3D PSIR BOOST. Moreover, bright‐blood  T2Prep and 
black‐blood PSIR BOOST images are shown in Fig. 7 for 
four representative patients, together with the clinical 2D 
PSIR acquisitions.
The LGE findings present in the 2D clinical PSIR 
images of patient 7 were reported as a non-ischemic 
cardiomyopathy (myocarditis). However, in the 3D 
BOOST PSIR images, LGE uptake was identified 
as a transmural myocardial  infarction. Therefore, 
Fig. 5 a Vessel length of the right (RCA) and left anterior descending (LAD) coronary arteries for all 12 healthy subjects obtained from the  T2Prep-IR 
BOOST reconstructions of fully-sampled (FS), 2.6 × and 3.8 × accelerated (Acc) BOOST datasets. Significant equivalence (p < 0.05) in visible vessel 
length was observed between the reconstructions obtained from fully-sampled and accelerated acquisitions, for both coronary arteries. b Vessel 
sharpness obtained from the fully-sampled and accelerated  T2Prep-IR BOOST images for all 12 healthy subjects. Image quality was assessed 
by measuring the first 4 cm and full length of the RCA and LAD. Measurements of vessel sharpness obtained for both coronary arteries were 
statistically equivalent (p < 0.05)
Table 1 Summary of  patients’ data.  In addition, the  presence of  LGE findings in  the  clinical 2D PSIR images is  stated. 
Patients 6 and  9 were not  considered for  the  quantitative analysis since  BOOST acquisitions started later than  40  min 
after contrast injection
BMI body mass index, HR heart rate, bpm beats per minute, LV left ventricle
Patient Gender Age (years) Weight (kg) Height (m) BMI (kg/m2) HR(bpm) Clinical condition Positive LGE
1 M 79 76 1.62 29 56 Dilated cardiomyopathy and myocardial infarc-
tion
Yes
2 M 68 66 1.47 31 52 Severe LV impairment and myocardial infarc-
tion
Yes
3 F 48 64 1.65 24 54 Dilated cardiomyopathy and fibrosis No
4 M 75 71 1.63 27 48 Dilated cardiomyopathy No
5 F 72 66 1.63 25 48 Myocarditis No
6 F 49 82 1.63 31 60 Myocardial infarction Yes
7 M 44 91 1.79 28 66 Myocarditis Yes
8 M 84 60 1.75 20 54 Ischemic cardiomyopathy No
9 M 82 101 1.81 31 70 Myocardial infarction No
10 M 55 67 1.65 25 86 Normal No
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correspondence between clinical 2D PSIR and 3D PSIR 
BOOST images was found in all the cases except for 
one patient with a non-ischemic cardiomyopathy. In 
addition, the consensus grading scores indicate that the 
bright-blood  T2Prep BOOST images allowed for visu-
alization of the proximal and middle LAD, LCX and 
RCA sections with high diagnostic quality (Fig. 8) and 
visualization of the distal sections of the RCA and LCX 
was fair. Nevertheless, all segments ultimately had diag-
nostic value.
Discussion
In this work, the respiratory-resolved motion-corrected 
XD-ORCCA reconstruction has been extended to accel-
erate the  T2-prepared BOOST sequence and achieve 
high-resolution motion-corrected 3D whole-heart black-
blood LGE and CCMRA, within clinically feasible acqui-
sition times. Respiratory-resolved images are obtained 
for each BOOST dataset  (T2Prep-IR and  T2Prep) using 
XD-ORCCA, which uses 2D translational motion infor-
mation extracted from iNAVs to increase the sparsity in 
the respiratory dimension and to compensate for residual 
motion within each respiratory bin. Then, the  T2Prep-IR 
and  T2Prep BOOST images are combined in a PSIR 
reconstruction to generate a dark-blood PSIR BOOST 
image.
Initially, the feasibility of using XD-ORCCA to accel-
erate the  T2-prepared BOOST acquisitions was tested 
using non-contrast-enhanced 3D BOOST acquisitions 
in healthy subjects. Fully-sampled BOOST acquisitions 
were compared against 2.6-fold and 3.8-fold accelerated 
BOOST scans. This study showed that the proposed 
framework produces high quality motion-compensated 
Fig. 6 Accelerated high-resolution 3D BOOST and clinical 2D 
PSIR images for one representative patient with myocardial 
infarction. a Bright-blood  T2Prep BOOST image (coronal view) and 
e corresponding reformatted image showing the LAD. b, f BOOST 
provides a black-blood PSIR image for LGE scar visualization (arrows), 
which shows good agreement with (d, h) clinical 2D PSIR. c, g Fusion 
between the bright-blood  T2Prep BOOST and the black-blood 
PSIR BOOST images allows the assessment of scar location and 
transmurality. The signal from both blood and viable myocardium 
is nulled in black-blood PSIR BOOST images, thus providing images 
with good contrast between the blood pool and scar tissue. LGE 
uptake can be seen (arrows) in the short-axis views b, c, d, f, g, h 
of the mid (top) and basal (bottom) anterolateral walls. Clinical 2D 
PSIR and BOOST were acquired ~ 10 min and ~ 35 min post-contrast, 
respectively
Fig. 7 Accelerated high-resolution 3D BOOST and clinical 2D PSIR 
images obtained for four patients. (left) Bright-blood  T2Prep BOOST 
coronal views for visualization of heart anatomy are displayed 
together with coronary reformats showing the left anterior 
descending (LAD), left circumflex (LCX), and right (RCA) coronary 
arteries. (middle) 3D black-blood PSIR BOOST images and (right) 
clinical bright-blood 2D PSIR images. Patient 1 had myocardial 
infarction and septal LGE uptake is visible in both PSIR BOOST and 
clinical 2D PSIR short-axis views (arrows). Patients 3, 4 and 5 had 
non-ischaemic cardiomyopathyies with no LGE uptake. Moreover, 
Patient 5 had a bioprosthetic aortic valve replacement, which is nicely 
depicted in the bright-blood  T2Prep image (arrows)
Fig. 8 Qualitative visual scores obtained for all eight patients for the 
proximal, middle and distal sections of the left anterior descending 
(LAD), right (RCA) and left circumflex (LCX) coronary arteries. 
Depiction of coronary artery course was graded using a 4-point 
scale system (1: non-diagnostic, 2: diagnostic with major artifacts, 
3: diagnostic with minor artifacts and 4: fully diagnostic with no 
artifacts). Bright-blood  T2Prep BOOST images allowed for visualization 
of the proximal and middle LAD, LCX and RCA segments with high 
diagnostic quality. All segments had diagnostic value
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images from 2.6-fold and 3.8-fold accelerated free-
breathing BOOST acquisitions. Equivalence tests with 
TOST revealed statistically significant equivalence 
in visible vessel length and sharpness when compar-
ing measurements from fully-sampled bright-blood 
BOOST image and undersampled BOOST images, for 
both coronaries. Therefore, acquisition times can be 
reduced from ~ 17 to ~ 6  min by using 3.8-fold acceler-
ated BOOST acquisitions, without significantly sacrific-
ing image quality. However, the fixed TI value used in 
this study is not the optimal for all subjects since TI is 
sensitive to the heart rate. Therefore, image quality could 
be improved by using of a subject-specific TI to suppress 
the fat signal and reduce chemical shift artefacts, such as 
those observed in Fig. 3.
The first study, using non-contrast-enhanced 3D 
BOOST acquisitions, was essential to select the optimal 
acceleration factor to be used in the contrast-enhanced 
BOOST study. It showed that XD-ORCCA can recon-
struct images from 3.8 × accelerated BOOST acquisi-
tions with comparable quality to those obtained from 
fully-sampled acquisitions. Thus, in the second study, 
3.8-fold accelerated post-contrast BOOST acquisitions 
were compared against clinical 2D PSIR in patients with 
suspected coronary artery disease. All 3D BOOST PSIR 
images included in the qualitative study had diagnos-
tic quality. Moreover, scar tissue could be identified in 
3D PSIR BOOST images despite image acquisition only 
starting on average 32 min after contrast administration. 
This was facilitated by the high contrast between scar tis-
sue and blood pool in 3D PSIR BOOST images compared 
to clinical 2D PSIR. Healthy viable myocardium and scar 
tissue (when present) were visible in matching anatomi-
cal locations for both the clinical 2D PSIR and the 3D 
whole-heart PSIR BOOST images. In addition, bright-
blood  T2Prep BOOST images allowed visualization of 
the origin, proximal and mid sections of the coronary 
arteries with high diagnostic quality. Hence, the pro-
posed framework successfully generates high-resolution 
3D whole-heart black-blood PSIR LGE and bright-blood 
coronary angiography images with sufficient diagnostic 
quality from 3.8-fold accelerated post-contrast BOOST 
acquisitions, which can be obtained in a clinically feasible 
scan time (~ 7 min).
For patient 2, septal LGE uptake was identified in the 
3D BOOST PSIR, but was not detected in the 2D clinical 
PSIR (Fig. 6). This finding could be because the proposed 
method provides high-resolution (1 × 1 × 2  mm3) black-
blood PSIR BOOST images with whole-heart volumetric 
coverage, whereas the clinical 2D PSIR images have lower 
in-plane resolution (1.4 × 1.4  mm2) and large slice thick-
ness (8 mm). Moreover, clinical 2D PSIR requires multi-
ple breath-holds, and hence, 2D PSIR images may not be 
in the same respiratory phase as the displayed 3D PSIR 
BOOST images. However, to draw conclusions, further 
studies in a large cohort of patients are necessary to com-
pare the location and extent of LGE in accelerated 3D 
PSIR BOOST and clinical 2D PSIR.
The number of respiratory bins used in both studies 
provides a good compromise between remaining intra-
bin motion and undersampling artifacts [32]. However, 
better results could potentially be achieved by adapting 
the number of respiratory bins according to the irregular-
ity and amplitude of the respiratory motion. One solution 
would be to add/remove respiratory bins until a fixed bin 
width is achieved (e.g. 3  mm). Additionally, arrhythmia 
rejection techniques can be integrated with the proposed 
framework to further improve imaging quality. At pre-
sent, the sequence requires relatively regular R-R inter-
vals and therefore cannot be used in patients with atrial 
fibrillation, although this is a limitation for many tech-
niques employed in clinical CMR.
Currently, it is assumed that the  T2Prep-IR BOOST 
and  T2Prep BOOST images generated with XD-ORCCA 
are registered, and hence, in the same respiratory posi-
tion. However, there could potentially be registration 
errors, which can cause phase errors in the PSIR BOOST 
images. The use of non-rigid registration to correct for 
residual non-rigid motion between the highest-quality 
 T2Prep-IR BOOST and bright-blood  T2Prep BOOST bin 
images was tested in a preliminary study in healthy sub-
jects, showing that the visual quality of the final 3D black-
blood PSIR BOOST image could be slightly improved 
(Additional file 3).
The proposed framework only considers translation 
motion along the SI and LR direction. However, res-
piratory-induced heart motion involves more complex 
motion patterns, including motion along the anterior–
posterior direction and even non-rigid deformation. 
Therefore, residual motion could be addressed by esti-
mating/correcting for 3D translational or non-rigid 
motion at each XD-ORCCA iteration. Alternatively, the 
high-quality respiratory XD-ORCCA images could be 
used to estimate 3D bin-to-bin non-rigid motion, which 
can subsequently be used to generate 3D  T2Prep-IR 
BOOST and  T2Prep BOOST non-rigid motion-corrected 
images [24]. Moreover, non-rigid respiratory motion 
correction may help reduce ghosting artefacts that may 
originate from rigid translation of static tissues such as 
the chest wall and arms. However, all these methods are 
computationally more expensive.
The proposed 3D PSIR BOOST requires separate 
reconstructions for each  T2Prep-IR and  T2Prep BOOST 
dataset. However, since this produces images of the 
same anatomical region with different contrasts, a joint 
sparsity regularization term could be added to Eq. (1) to 
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exploit the structural similarity (sparsity) across contrasts 
and jointly reconstruct  T2Prep-IR and  T2Prep BOOST 
images. This approach could potentially provide higher 
quality images than reconstructing the  T2Prep-IR and 
 T2Prep BOOST images separately [33–35].
In this study, post-contrast BOOST acquisitions were 
performed at the end of the clinical CMR examination 
so that the research protocol did not interfere with the 
clinical CMR exam indicated to diagnose suspected car-
diovascular disease. Therefore, injection of contrast agent 
was optimized to provide optimal contrast for the clini-
cal 2D PSIR sequences and the order of the 2D PSIR and 
3D BOOST acquisitions was not randomized as per ethi-
cal requirements. Thus, post-contrast BOOST acquisi-
tions had potentially sub-optimal contrast conditions. 
This was particularly evident for two specific cases that 
were excluded of the qualitative analysis (patient 6 and 
patient 9). Moreover, additional challenges can occur by 
performing BOOST acquisitions at the end of the clinical 
protocol, for example, patients’ tolerance to being inside 
the scanner reduces with time and there can be more 
respiratory and heart rate variability that can have a det-
rimental effect on image quality. Therefore, accelerated 
high-resolution post-contrast 3D BOOST and clinical 
2D PSIR acquisitions will be compared in a future study 
by randomizing the order of the two acquisitions and by 
performing separate contrast injections to ensure simi-
lar contrast conditions. Future studies will also aim to 
investigate the accuracy of black-blood PSIR BOOST for 
the detection and quantification of scar transmurality in 
patients with angiographically confirmed coronary artery 
disease.
Patient 7 had a non-ischemic cardiomyopathy (myo-
carditis), which was identified as a myocardial infarct 
in the BOOST PSIR images. This could be due the lack 
of contrast between  the healthy myocardium and blood 
pool, which gives the impression that the fibrosis is sub-
endocardial when, in fact, it is located in the mid myo-
cardial wall. Moreover, BOOST imaging started more 
than 30 min post-contrast injection, and hence, contrast 
agent washout could have prevented adequate scar depic-
tion. However, a more accurate location and delineation 
of scar tissue can be obtained by fusing the black-blood 
PSIR image with the bright-blood  T2Prep BOOST image, 
which then allows both scar and myocardial anatomy vis-
ualization as shown in Fig. 6. Alternatively, a grey-blood 
PSIR technique can be used, which is optimized to null 
the blood pool, leading to a gray appearance of the blood 
in the PSIR image, and hence, offering better contrast 
between myocardium and blood pool [36, 37]. Neverthe-
less, the ability of the proposed method to discriminate 
between ischemic and non-ischemic cardiomyopathies 
needs to be evaluated and will also be the subject of 
future studies.
The accelerated high-resolution non-contrast-
enhanced BOOST showed promising results for both 
bright blood and black‐blood coronary artery imag-
ing. However, the suitability of the proposed method 
for detecting coronary thrombus still needs to be inves-
tigated. Nevertheless, this indicates that the proposed 
framework is quite versatile and could potentially be used 
with other free-breathing LGE or PSIR techniques [38, 
39].
Conclusions
An accelerated 3D whole-heart  T2-prepared BOOST 
framework was proposed to provide high-resolution 3D 
whole-heart bright-blood and black-blood PSIR BOOST 
images within a clinically feasible scan time of ~ 7  min. 
This was achieved by combining the XD-ORCCA respir-
atory-resolved reconstruction method with free-breath-
ing 3D whole-heart Cartesian BOOST undersampled 
acquisitions. The proposed method was tested in a group 
of cardiac patients and showed a good agreement with 
the clinical 2D PSIR LGE.
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Additional file 1: Fig. S1. Subject 3 reconstructions (coronal views) 
obtained from fully-sampled, 2.6x and 3.8x accelerated T2Prep-IR BOOST 
data. The tortuous anatomy of the RCA prevented an appropriate 
multiplanar reformatting of the mid segment of the vessel. However, the 
zoomed areas (yellow boxes) of the non-reformatted coronal views show 
that the mid-RCA was successfully reconstructed from fully-sampled and 
accelerated BOOST acquisitions using the proposed method. Coronal 
view numbers are indicated in each subfigure.
Additional file 2: Fig. S2. Coronal views showing the T2Prep-IR BOOST 
and PSIR BOOST images reconstructed from fully-sampled, 2.6 x and 3.8x 
undersampled non-contrast-enhanced BOOST datasets, for a representa-
tive healthy subject. Images obtained from accelerated acquisitions have 
comparable quality to those obtained from fully-sampled acquisitions. The 
complete heart anatomy and coronary arteries can be clearly visualized in 
all the images.
Additional file 3: Fig. S3. 3D black-blood PSIR BOOST coronal views 
obtained (1st and 3rd rows) without (No MA) and (2nd and 4th rows) 
with non-rigid motion alignment (NMC) between the T2Prep-IR BOOST 
and T2Prep BOOST bin images before the PSIR reconstruction, for two 
representative healthy subjects. The proposed method assumes that the 
highest quality T2Prep-IR BOOST and T2Prep BOOST bin images are reg-
istered. However, there could be some residual non-rigid motion. Hence, 
non-rigid registration was used to correct for residual non-rigid motion 
between the T2Prep-IR BOOST and bright-blood T2Prep BOOST bin 
images. The visual quality of the final 3D black-blood PSIR BOOST image 
improved slightly when non-rigid motion alignment was used between 
the T2Prep-IR and T2Prep BOOST images.
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